Inicio › Linfoma de células B › Nueva York › New York City
Ensayos clínicos de Linfoma de células B en New York City, NY
18 estudios para Linfoma de células B buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
ReclutandoFase 3
- Memorial Sloan Kettering Cancer Center Mskcc, New York
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- New York University (NYU) Clinical Cancer Center, New York
- Weill Cornell Medicine, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Medical Center, New York
- Weill Cornell Medical College Newyork Presbyterian Hospital, New York
- y 1 más
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
ReclutandoFase 2
- Research Site, New York
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
ReclutandoFase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
ReclutandoFase 1/2
- Research Site, New York
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
ReclutandoFase 1
- Clinical Trial Site, New York
- Clinical Trial Site, New York
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
ReclutandoFase 1/2
- Research Site, New York
A Study of ARC-02 in B-cell NHL
ReclutandoFase 1
- NYU Langone, New York
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
ReclutandoFase 1/2
- Research Site, New York
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
ReclutandoFase 1/2
- Memorial Sloan Kettering, New York
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
ReclutandoFase 2
- Columbia University Irving Medical Center, New York
Study of CAR-T Therapy in Older Patients
ReclutandoEstudio observacional
- Memorial Sloan Kettering Cancer Center, New York
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL
Reclutando
- Columbia University, New York
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
Reclutando
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
- NEW YORK PRESBYTERIAN HOSPITAL (Data Collection Only), New York
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
ReclutandoFase 1
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
Ensayos de Linfoma de células B en otras ciudades
- Houston, TX16 estudios
- Chicago, IL13 estudios
- Nashville, TN11 estudios
- Philadelphia, PA11 estudios
- Rochester, MN10 estudios
- Baldwin Park, CA9 estudios
- Cleveland, OH9 estudios
- Milwaukee, WI9 estudios
- Salt Lake City, UT8 estudios
- Boston, MA8 estudios
- Washington, DC7 estudios
- Pittsburgh, PA7 estudios
Otros estudios en New York City
- Cáncer de seno137 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)110 estudios
- Cáncer de próstata102 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario70 estudios
- Cáncer de páncreas60 estudios
- Mieloma múltiple60 estudios
- Cáncer de pulmón60 estudios
- Cáncer de endometrio52 estudios
- Fallo cardíaco51 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.